user login

Heart-type Fatty Accid Binding Protein immuno assay- H/FBP (chemiluminescence )

Min. Order: 1000 Piece/Pieces
Trade Term: FOB,CFR,CIF,DAT,FAS,DDP,DAP,CIP,CPT,FCA,EXW
Payment Terms: Paypal, L/C, D/P, D/A, T/T, WU, Money Gram
Supply Ability: 1,000,000.00/Month
Place of Origin: Jiangsu

Company Profile

Location: Nanjing, Jiangsu, China (Mainland)
Business Type: Manufacturer

Product Detail

Model No.: H-FABP
Means of Transport: Ocean, Air, Land
Brand Name: NORMAN
Methodology: Chemiluminescence immunoassay
Brand Name: Norman
Place of Origin: Jiangsu, China (Mainland)
Quality system certificate: ISO13485
Test quantity of one box: 100 test
Reagent type: liquid
Test platform: Norman 411
Production Capacity: 1,000,000.00/Month
Packing: CARTON
Delivery Date: TWO WEEKS AFTER PAYMENT
Show

Product Description

           Heart-type Fatty Accid Binding Protein  

                           immuno assay- H/FBP                                                                (chemiluminescence )


H-FABP                                                                                           


Registration No: Jiangsu food and drug administration 2014-2400619

H-FABP increase in 30 minutes after Acute Myocardial Infarction(AMI) occurred ,

Early marker of AMI.

Mainly indicated in the heart,high specificity for diagnosis of AMI

 

Clinical Signifacanse                                                                 


Early specific markers of AMI 

Rapid risk stratification of AMI

Early prognosis Evaluation ofAMI patients

Perfect markers for early testing of re-infarction

Norman Advantages                                                                  


Hign sensitivity:0.5ng/ml

High accuracy: 99% result correlation with Hycult H-FABP ELISA

Wide Linear range:0.5-160ng/ml


Correlation analysis between Norman H-FABP and Hycult H-FABP ELISA


 

 

Significance of united application of H-FABP

and cTnI


Conductively screen out patients with high risk of heart disease ifH-FABP is tested 

at early phaseand cTnIis tested at recovery phase.

Not only convenient to take active treatment strategies, but also save the expenses 

of patients and laboratory resources.

Complementary test of H-FABP and cTnIis aperfect choice for clinical diagnosis and

treatment of ischemic heart disease.


Assay platform                                                                             

Norman chemiluminesence immunassay system


Related assays                                                                              

About us                                                                                         

Nanjing Norman Biological Technology Co., Ltd is dedicated to R&D and manufacturing of 

in vitro diagnostic instruments and reagents. .Founded in 2008, Norman biological has 

been upholding the idea that R&D shapes future ,and concentration determines success. 

Ever since the beginning, Norman has been focusing on developing and manufacturing 

chemiluminescence and immunofluorescence  reagents.

Agent Wanted                                                                              

If you are interested in working with us, please feel free to contact.


Post Buying Request